Summary of Analyst Ratings Tips: Fiesta Restaurant Group, Inc. (FRGI), Global Blood Therapeutics Inc. (GBT)

The opening price for Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) was $18 and the volume amounted to 0.33 million shares which compares with the average volume of 0.37 million shares. The company stock experienced a 4.19% move to arrive at $18.65.

Fiesta Restaurant Group, Inc. (FRGI) Analyst Opinion

Fiesta Restaurant Group, Inc. has a consensus outperform rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 12.11% of shares outstanding. The stock spiked 12.01% last month and is down -37.52 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover FRGI having a buy-equivalent rating. Analysts have placed a $18 price target on Fiesta Restaurant Group, Inc., suggesting a -3.49% decline from recent close. It’s currently trading about -39.15% below its 52-week high.

Fiesta Restaurant Group, Inc. Earnings Surprise

Fiesta Restaurant Group, Inc. (FRGI) revenue totaled $162.24 million down -6.01% from the previous quarter.

Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) Intraday View

This stock (FRGI) is ahead of its 52-week low with 20.32%. Its last month’s stock price volatility remained 4.68% which for the week stands at 4.79%. The share price has moved forward from its 20 days moving average, trading at a distance of 8.73% and stays 6.89% away from its 50 days moving average. Over the last five days, shares have managed 3.9% gains and now is down -7.77% since hitting its 200-day moving average of $18.68. Fiesta Restaurant Group, Inc. (FRGI) has made its way to a 12-month decline of -35.69%.

Turning to Global Blood Therapeutics Inc. (NASDAQ:GBT), its shares were trading at $37.4 a retreat of $-1.85, on the trading floor. The stock, after opening at $39.2, touched a high of $39.6 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Global Blood Therapeutics Inc. has 4 buy ratings, 1 holds and 0 sells even after the stock tumbled -14.9% from its high of $43.95 to a $1.6 billion market value through last close.

Global Blood Therapeutics Inc. (GBT) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 1.77 to 1.77 during a month. Analysts set a 12-month price target of $58.25 a share. The target implies a 55.75% spike from where the shares are currently trading. Also, the current price highlights a discount of 121.93% to analysts’ high consensus price target.

Global Blood Therapeutics Inc. (NASDAQ:GBT) Intraday Trading

The counter witnessed a trading volume of 0.67 million shares versus an average volume of 0.9 million shares during last trading session. Its last month’s stock price volatility remained 3.6% which for the week approaches 6.07%. The lowest price the stock reached in the last trading day was $37.25 and compares with the $13.35 52-week low. The stock recovered 180.15% since its low point and has performed 158.82% year-to-date.

Previous articleWall Street Analyst Actions To Watch: STAAR Surgical Company (STAA), Five Prime Therapeutics, Inc. (FPRX)
Next articleAnalyst Opinion On How To Bet On Enbridge Energy Partners, L.P. (EEP), IAC/InterActiveCorp (IAC)